HC Wainwright & Co. reiterates Xenetic Biosciences [XBIO] rating to Buy and sets new price target at $$2.50
HC Wainwright & Co. maintained its Xenetic Biosciences [XBIO] rating to the equivalent of Buy but changed the price target to $5.0 from $2, in a research note dated 2021-01-11. That figure represents around a 106.61% premium from where the company’s shares closed on Friday. Get the hottest stocks to trade every day before the […]
